Innovating Works

HapticCell

Financiado
Haptic micromanipulation system for low cost autonomous microinjection tasks
The ability to handle and operate on cells is an emerging technology that will accelerate the development of novel cell-based therapies. By being able to modify donor cells in-vitro to fight disease more effectively and in volume... The ability to handle and operate on cells is an emerging technology that will accelerate the development of novel cell-based therapies. By being able to modify donor cells in-vitro to fight disease more effectively and in volume will have paradigm shifting advances in a wide range of fields such as biotechnology, pharmacology, agriculture, oncology, genetics and embryology. As highlighted by the Innovate UK Cell Therapy Catapult, by 2017 the cell-based therapy manufacturing industry will be worth more than €4.5billion. To realise this opportunity, it is vital clinicians and manufacturers have access to efficient tools that are also repeatable. Several methods exist that enable the manual manipulation of cells, amongst which microinjection tasks is the most common. However, current techniques are labour intensive, vary in quality, and lack the measurement of force between the tools used and the cell needed to reduce damage during contact. Moreover, as these processes are not automated and can only be performed one cell at a time, it is prohibitively expensive to produce new cell-based therapies at the volumes needed for clinical trials. To address these unmet needs, we present ‘HapticCell’, a robotic micromanipulation platform for low cost autonomous microinjection tasks. In this ERC-PoC project, we will extend our ERC research in telehaptic micromanipulation to support schemes for automation and establish its technical feasibility in performing repeatable microinjection tasks in volume appropriate for clinical needs. Further, in collaboration with spin out company Yantric, UCL Business and identified first customers, we will conduct the necessary commercial activities to translate HapticCell into the real world. To start, we envisage HapticCell to be an indispensable tool for achieving higher throughput in the in-vitro fertilisation (IVF) market, which will then act as a stepping stone into the broader single cell manipulation domain and cell-therapy production. ver más
31/01/2018
UNIVERSITY COLLEGE...
150K€
Duración del proyecto: 12 meses Fecha Inicio: 2017-01-24
Fecha Fin: 2018-01-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2018-01-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
ERC-PoC-2016: ERC-Proof of Concept-2016
Cerrada hace 8 años
Presupuesto El presupuesto total del proyecto asciende a 150K€
Líder del proyecto
UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5